By designing vaccines that stimulate the body’s own production of antibodies against disease-associated proteins, such as inflammatory cytokines, misfolded proteins, or metabolic regulators, it may be possible to establish long-term immunological control over conditions like Alzheimer’s disease, atherosclerosis, and certain cancers [87]. Here, PROS1 is linked to early-onset autosomal dominant Alzheimer disease.